Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC)

Pancreatology

Volumn 15, Issue 3, 2015, Pages 295-301

  Hiroshima, Yukihiko ^a,b,c   Maawy, Ali ^b   Zhang, Yong ^a   Murakami, Takashi ^c   Momiyama, Masashi ^c   Mori, Ryutaro ^c   Matsuyama, Ryusei ^c   Chishima, Takashi ^c   Tanaka, Kuniya ^c   Ichikawa, Yasushi ^c   Endo, Itaru ^c   Hoffman, Robert M ^a,b   Bouvet, Michael ^b  

^a ANTICANCER INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

CEA; Fluorescence guided surgery; Neoadjuvant chemotherapy; Pancreatic cancer; Patient derived orthotopic xenograft; PDOX

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GEMCITABINE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; FLUORESCENT DYE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRIGHT LIGHT SURGERY; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER TRANSPLANTATION; FLUORESCENCE GUIDED SURGERY; HISTOPATHOLOGY; HUMAN; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; TAIL VEIN; TUMOR XENOGRAFT; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ANALOGS AND DERIVATIVES; ANIMAL; COMPARATIVE STUDY; DRUG RESISTANCE; EVALUATION STUDY; FLUORESCENCE IMAGING; LIGHT; NEOADJUVANT THERAPY; NONOBESE DIABETIC MOUSE; NUDE MOUSE; PANCREAS RESECTION; PANCREATIC NEOPLASMS; PREVENTION AND CONTROL; PROCEDURES; RANDOMIZATION; TREATMENT OUTCOME; TUMOR RECURRENCE; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; FLUORESCENT DYES; HETEROGRAFTS; HUMANS; LIGHT; MICE; MICE, INBRED NOD; MICE, NUDE; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; OPTICAL IMAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; RANDOM ALLOCATION; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 84930177963     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2015.02.008     Document Type: Article

References (23)

1. K. Kato, S. Yamada, H. Sugimoto, N. Kanazumi, S. Nomoto, and S. Takeda Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival Pancreas 38 2009 605 612
2. M. Bouvet, and R.M. Hoffman Glowing tumors make for better detection and resection Sci Transl Med 3 2011 110fs110
3. E.L. Rosenthal, and K.R. Zinn Putting numbers to fluorescent guided surgery Mol Imaging Biol 15 2013 647 648
4. S. Kaushal, M.K. McElroy, G.A. Luiken, M.A. Talamini, A.R. Moossa, and R.M. Hoffman Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer J Gastrointest Surg 12 2008 1938 1950
5. M. McElroy, S. Kaushal, G.A. Luiken, M.A. Talamini, A.R. Moossa, and R.M. Hoffman Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA 19-9 antibody for surgical navigation World J Surg 32 2008 1057 1066
6. C.A. Metildi, S. Kaushal, C.R. Hardamon, C.S. Snyder, M. Pu, and K.S. Messer Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models J Am Coll Surg 215 2012 126 135 discussion 135-126
7. Y. Hiroshima, A. Maawy, C.A. Metildi, Y. Zhang, F. Uehara, and S. Miwa Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-cea antibody and a portable imaging system J Laparoendosc Adv Surg Tech A 24 2014 241 247
8. X.Y. Fu, J.M. Besterman, A. Monosov, and R.M. Hoffman Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens Proc Natl Acad Sci U S A 88 1991 9345 9349
9. M.P. Kim, D.B. Evans, H. Wang, J.L. Abbruzzese, J.B. Fleming, and G.E. Gallick Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice Nat Protoc 4 2009 1670 1680
10. T. Furukawa, T. Kubota, M. Watanabe, T.H. Kuo, M. Kitajima, and R.M. Hoffman Differential chemosensitivity of local and metastatic human gastric cancer after orthotopic transplantation of histologically intact tumor tissue in nude mice Int J Cancer 54 1993 397 401
11. D.B. Evans, G.R. Varadhachary, C.H. Crane, C.C. Sun, J.E. Lee, and P.W. Pisters Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 2008 3496 3502
12. M.H. Katz, G.R. Varadhachary, J.B. Fleming, R.A. Wolff, J.E. Lee, and P.W. Pisters Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation Ann Surg Oncol 17 2010 1794 1801
13. H. Takahashi, H. Ohigashi, O. Ishikawa, H. Eguchi, K. Gotoh, and T. Yamada Serum CA19-9 alterations during preoperative gemcitabine-based chemoradiation therapy for resectable invasive ductal carcinoma of the pancreas as an indicator for therapeutic selection and survival Ann Surg 251 2010 461 469
14. M.H. Katz, J.B. Fleming, P. Bhosale, G. Varadhachary, J.E. Lee, and R. Wolff Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators Cancer 118 2012 5749 5756
15. X. Fu, F. Guadagni, and R.M. Hoffman A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens Proc Natl Acad Sci U S A 89 1992 5645 5649
16. T. Furukawa, T. Kubota, M. Watanabe, M. Kitajima, and R.M. Hoffman A novel "patient-like" treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice Cancer Res 53 1993 3070 3072
17. R.M. Hoffman Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic Invest New Drugs 17 1999 343 359
18. C.A. Metildi, S. Kaushal, G.A. Luiken, M.A. Talamini, R.M. Hoffman, and M. Bouvet Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model J Surg Oncol 109 2014 451 458
19. A.A. Maawy, Y. Hiroshima, S. Kaushal, G.A. Luiken, R.M. Hoffman, and M. Bouvet Comparison of a chimeric anti-carcinoembryonic antigen antibody conjugated with visible or near-infrared fluorescent dyes for imaging pancreatic cancer in orthotopic nude mouse models J Biomed Opt 18 2013 126016
20. K. Yamauchi, M. Yang, P. Jiang, M. Xu, N. Yamamoto, and H. Tsuchiya Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system Cancer Res 66 2006 4208 4214
21. D.B. Evans, T.A. Rich, D.R. Byrd, K.R. Cleary, J.H. Connelly, and B. Levin Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas Arch Surg 127 1992 1335 1339
22. C.A. Metildi, S. Kaushal, M. Pu, K.A. Messer, G.A. Luiken, and A.R. Moossa Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer Ann Surg Oncol 21 2014 1405 1411
23. Y. Hiroshima, A. Maawy, S. Sato, T. Murakami, F. Uehara, and S. Miwa Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice J Surg Res 187 2014 510 517